Shares of Ketamine One Capital Limited (OTCMKTS:KONEF) have been trading within a narrow range. The stock has lost 30% in the past month.
Trading Data
On Tuesday, KONEF stock decreased by 3% to $0.3368 with more than 200 shares traded, compared to its average volume of 700 shares. The stock has moved within a range of $0.3368 – 0.3368 after opening trading at $0.3368.
Ketamine One Appoints Joe Ramelli as Its New Chief Financial Officer
Company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, KetamineOne Capital Limited (OTCMKTS:KONEF) on December 14, 2021, announced that Joe Ramelli has been appointed as the new Chief Financial Officer starting December 14, 2021.
Having a Bachelor of Arts in Business Economics from the University of California, Santa Barbara, and attended Director Education and Certification Program at UCLA’s Anderson School of Management, Joe has about three decades of experience in Biotechnology and public markets.
Ramelli is an experienced investor and consultant specializing in business strategic planning, capital raising, corporate governance, and talent acquisition.
He has served as Interim CFO at ValenzaBio, a privately held biopharmaceutical company. Ketamine One’s former CFO, Peter Nguyen, has agreed on departing for facilitating Mr. Ramelli’s transition.
Adam Deffett, Interim CEO of Ketamine One said that he is pleased on welcoming Joe to Ketamine One’s management team. Deffett added that Ramelli comes to the organization as a highly recommended professional and is keen on learning from the expertise.
Deffett expressed gratitude to Peter for his services to Ketamine One and appreciates efforts in helping the company become a public issuer.
KetamineOne Capital is working on providing the critical infrastructure needed for developing and delivering breakthrough mental health treatments.
Technical Data
KONEF stock is trading above the 20-Day and 50-Day Moving averages of $0.32 and $0.32 respectively. However, the stock is trading above the 200-Day moving average of $0.87. The stock is down 8% in the past month.
